Purchase Order N3239824P0030
Award Date
8/7/24
Potential Completion Date
9/30/24
Potential Value
$39K
Federal Agency
Bureau of Medicine and Surgery
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20910, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract is for the first shipment of MiSeq reagents, with a ceiling value of $130,556.94 and a completion date of September 30, 2024. Illumina has previously received prime contracts and subcontracts from various civilian and defense agencies to provide sequencing instruments, reagents, and associated...
This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract is for the procurement of MISEQ REAGENT K, catalog number MS-102-3003, with a ceiling value of $57,329.00 and a period of performance ending on July 30, 2021. The contract is not associated with a set-aside designation and is not part of a larger...
This is a firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of the Navy, to Illumina, Inc. The contract is valued at $74,271.29 and is for the provision of an MS-102-3003 MiSeq Reagent Kit. Illumina is a manufacturer of genomic sequencing instruments and reagents, and has a track record of providing these products and services to federal agencies for research and diagnostic applications. The Bureau of Medicine and Surgery...
This is a firm fixed price purchase order awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Illumina, Inc., a manufacturer of genomic sequencing instrumentation and reagents. The $153,192.00 contract is for the provision of a MiSeq Silver sequencing system and associated products to support the agency's nucleic acid sequencing needs, specifically to characterize biological threats at the Naval Medical Research Center's Biological Defense Research...
This is a firm fixed price delivery order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The contract is for the provision of MiSeq Reagent Kits, with a total ceiling value of $416,882.75 and a completion date of September 13, 2017. The contract has no set-aside designation. Illumina has previously received both prime and subcontract awards from federal agencies such as the National Institutes of...
This is a firm fixed price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The order is for the procurement of a MiSeq Reagent Kit V3 (600 cycle) with a ceiling value of $38,877.12. There was no set-aside used for this award. Illumina has received numerous prior prime contract awards from federal agencies like NIH, CDC,...
This is a federal delivery order contract awarded by the Bureau of Medicine and Surgery, a defense agency, to Illumina, Inc., a leading manufacturer of genetic sequencing technologies. The contract is for the procurement of MiSeQ Reagent Kit V3, which are consumables used with Illumina's MiSeq DNA sequencing platform. The contract has a fixed price with economic price adjustment, a ceiling value of $72,259.56, and a performance period ending on March 31, 2025. The contract does not have a...
This is a firm fixed price contract awarded by the Southeast Area of a civilian federal agency to Illumina, Inc., a manufacturer of genomic sequencing systems and related products. The contract is for the delivery of MiSeq reagent kits, control kits, and wash tubes, with a ceiling value of $12,300.62. There is no set-aside designation for this contract. Through past prime federal contract awards, Illumina has provided a range of genomic sequencing instruments, reagents, and services to support...
This is a firm fixed price delivery order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of MiSeq reagent kits, with a ceiling value of $210,099.09 and a completion date of September 28, 2017. The contract does not have a set-aside designation. Illumina is a well-established provider of sequencing systems and related products to various government agencies, including the...
This is a firm-fixed-price purchase order awarded by the Naval Medical Research Command to Illumina, Inc., a for-profit manufacturer of genomic sequencing technologies. The requirement is for a MiSeq i100 Plus System, a specialized DNA/RNA sequencing instrument. The $90,997.20 contract has an ultimate completion date of July 30, 2025. Illumina is a prime contractor providing a range of genomic sequencing platforms, reagents, consumables, and maintenance services to multiple federal civilian...